35986841_10216840653711318_1105697261150535680_n
Normal view MARC view ISBD view

Pharmacokinetics and pharmacogenomics of cyclophosphamide in Rhabdomyosarcoma patients العضليه المخططه الساروكميه مرضى فل سيكلوفوسفاميد الجينوميه الصيدله و علم الدوائيه الخرائك // GP // DR.Rania Mohamed Labib // TA. Salma Wagih (2017-2018)

By: [Nyera Hamdy Ibrahim 141797].
Contributor(s): Loubna Mustafa Ibrahim 140507 | Merna Ashraf Milad 141481.
Material type: materialTypeLabelBookPublisher: Giza : MSA 2018Description: 77 P. 30 CM.Subject(s): Pharmacy -- Clinical Pharmacy -- Pharmacokinetics & pharmacogenomicsDDC classification: 615 Online resources: FULL TEXT PRESS HERE Summary: renewing and asymmetric division that differentiate inside the body into for example , Somatic cells. Stem cell is possible to identify two large potential application fields of stem cells in diabetes mellitus: The reconstruction of β cell mass, and helps in the treatment of complications. Our target, find the mechanisms responsible for the effectiveness of bone marrow-derived mesnchymal stem cells in the suppression of DM Type 1. Experimental design: Eighteen male Albino Wistar rats divided into three groups , each Group having Six Rat Group I normal not diabetic and not suffering from any biochemical disorder, Group II Rats which are STZinduced diabetes group, Group III will be the Mesnchymal stem cells treated group MSCs (1×105 cells/rat) injected via tail veins in rats with STZ-induced diabetes. Blood glucose was measured spectrophotometry, Interleukin 6 and GLUT4 were measured by Elisa, insulin genes 1 and insulin genes 2 were measured by Real-time PCR. Insulin genes 1, insulin genes 2 and GLUT4 levels were significantly elevated in treated group compared to diabetic group (1). Interleukin 6 and blood glucose levels were significantly decreased in treated group compared to diabetic group. Mesnchymal stem cells may play an important role in treatment of T1DM
List(s) this item appears in: PHARMACY Distinguished Graduation Projects - Year 2017/2018
Tags from this library: No tags from this library for this title. Log in to add tags.
    average rating: 0.0 (0 votes)
Item type Current location Call number Status Date due Barcode
Distinguished Graduation Projects Distinguished Graduation Projects Soft Copy located on INTERNET GP33PH2018CL.Pharmacy (Browse shelf) Available 81954

Pharmacy-Clinical Pharmacy

renewing
and asymmetric division that differentiate inside the body into
for example , Somatic cells. Stem cell is possible to identify two large
potential application fields of stem cells in diabetes mellitus: The
reconstruction of β cell mass, and helps in the treatment of complications.
Our target, find the mechanisms responsible for the effectiveness of bone
marrow-derived mesnchymal stem cells in the suppression of DM Type 1.
Experimental design: Eighteen male Albino Wistar rats divided into three
groups , each Group having Six Rat Group I normal not diabetic and not
suffering from any biochemical disorder, Group II Rats which are STZinduced
diabetes group, Group III will be the Mesnchymal stem cells
treated group MSCs (1×105 cells/rat) injected via tail veins in rats with
STZ-induced diabetes. Blood glucose was measured spectrophotometry,
Interleukin 6 and GLUT4 were measured by Elisa, insulin genes 1 and
insulin genes 2 were measured by Real-time PCR. Insulin genes 1, insulin
genes 2 and GLUT4 levels were significantly elevated in treated group
compared to diabetic group (1). Interleukin 6 and blood glucose levels
were significantly decreased in treated group compared to diabetic group.
Mesnchymal stem cells may play an important role in treatment of T1DM

There are no comments for this item.

Log in to your account to post a comment.

Click on an image to view it in the image viewer